Cited by 28Bone Tissue Engineering MaterialsBone Metabolism and DiseasesTissue Engineering and Regenerative Medicine

The immunomodulatory effects of RNA-based biomaterials on bone regeneration

Open access
Wang, Chen-yu, Qin, Zi-xuan, Wei, Yu, Hao, Jia-xin, Zhu, Yi-fei, Zhao, Fei, Jiao, Kai, Ehrlich, Hermann +2 more·2023·Acta Biomaterialia

Abstract

The use of RNA as therapeutic agents is a visionary idea in contemporary medicine. Some forms of RNA can modulate the immune response of the host to enhance tissue regeneration events such as osteogenesis. Herein, RNA molecules commercially available for immunomodulatory applications (imRNA) were used to prepare biomaterials for bone regeneration. The polyanionic imRNA stabilized calcium phosphate ionic clusters to produce imRNA-ACP that had the capacity to mineralize the intrafibrillar compartments of collagen fibrils. For the first time, it was shown that incorporating imRNA-ACP into collagen scaffolds resulted in rapid new bone formation in cranial defects of mice. Both in vivo and in vitro results demonstrated that macrophage polarization was highly-sensitive to the imRNA-ACP containing collagen scaffolds. Macrophages were polarized into the anti-inflammatory M2 phenotype that produced anti-inflammation cytokines and growth factors. The favorable osteoimmunological microenvironment created by the scaffolds prevented their immunorejection and facilitated osteogenesis. The potential of RNA in creating immunomodulatory biomaterials has been underestimated in the past. The overall aim of this study was to explore the potential application of imRNA-based biomaterials in bone tissue engineering, with the competitive edge of facile synthesis and excellent biocompatibility. STATEMENT OF SIGNIFICANCE: In this work, commercially available RNA extracted from bovine spleens for immunomodulatory applications (imRNA) were used to stabilize amorphous calcium phosphate (ACP) and induce mineralization within collagen fibrils. Incorporation of imRNA-ACP into collagen scaffolds regenerated new bone in-situ. Because of its immunomodulatory effects, the imRNA-ACP that was incorporated into collagen scaffolds modulated the local immune environment of murine cranial defects by altering the macrophage phenotype through JAK2/STAT3 signaling pathway. The novelty of this work existed in the discovery of RNA's potential in creating immunomodulatory biomaterials. With the competitive edge of facile synthesis and excellent biocompatibility, the imRNA-based biomaterials are potentially useful for future bone tissue engineering applications.

Integrity signals

Registry

Crossref · 10.1016/j.actbio.2023.03.031

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the subsequent repair phase, as the coating degrades and controlled corrosion of the Mg substrate proceeds, sustained release of H2, Mg2+/Zn2+ facilitates transition to the M2 phenotype, supporting tissue repair and mitigating inflammation-induced osteolysis.

    “(2) In the subsequent repair phase, as the coating degrades and controlled corrosion of the Mg substrate proceeds, sustained release of H2, Mg2+/Zn2+ facilitates transition to the M2 phenotype, supporting tissue repair and mitigating inflammation-induced osteolysis [59].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, C.-Y., Qin, Z.-X., Wei, Y., Hao, J.-X., Zhu, Y.-F., Zhao, F., Jiao, K., Ehrlich, H., Tay, F. R., & Niu, L.-N.
Affiliations
  • Air Force Medical University (CN)
  • Adam Mickiewicz University in Poznań (PL)
  • Augusta University (US)
  • Stomatology Hospital (CN)
Corresponding author
  • Ehrlich, Hermann
  • Tay, Franklin R.
  • Niu, Li-na
Venue
Acta Biomaterialia
Publisher
Elsevier BV
Published
2023-05
Volume
162
Pages
32-43
ISSN
1742-7061 (ISSN-L)
OpenAlex
W4360798173
Cited by
28
References
39
Citations by year
2026: 5 · 2025: 13 · 2024: 6 · 2023: 4
FWCI
2.22
Type
journal article
Language
en
Open access
Locations
  • Acta Biomaterialia (publishedVersion)
  • SSRN Electronic Journal (acceptedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81870805)
  • Narodowe Centrum Nauki (2020/37/B/ST5/ 01909, 2020/38/A/ST5/00151)
  • National Key Research and Development Program of China (2022YFC2405900, 2022YFC2405901)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
immunomodulation, bone regeneration, bone tissue engineering, amorphous calcium phosphate, collagen scaffolds, macrophage polarization, M2 phenotype, bone formation, cranial defects, JAK2/STAT3 signaling, immune rejection
MeSH terms
Animals, Biocompatible Materials, Bone Regeneration, Calcium Phosphates, Cattle, Collagen, Osteogenesis, Tissue Engineering, Mice, Tissue Scaffolds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review